Large-scale genomic studies, such as The Cancer Genome Atlas (TCGA) project, have provided critical insights into the genomic landscape and heterogeneity of breast cancer, revealing a higher frequency of ESR1 mutations in MBC. Here, ESR1 is linked to breast cancer.